VAXFYVEO
Live / Registered — Registered (as of 14 May 2024)
What this means for you
Registered since 14 May 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97251112
- Registration number
- 7383743
- Mark type
- Stylized text
- Filed
- 02 Feb 2022
- Published for opposition
- 27 Feb 2024
- Registered
- 14 May 2024
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines
Owner
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
Prosecution history
- 14 May 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 May 2024 — REGISTERED-PRINCIPAL REGISTER
- 04 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Feb 2024 — PUBLISHED FOR OPPOSITION
- 07 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Jan 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Jan 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 22 Jan 2024 — LETTER OF SUSPENSION E-MAILED
- 22 Jan 2024 — SUSPENSION LETTER WRITTEN
- 22 Jan 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Jan 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Jan 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Jan 2024 — ASSIGNED TO LIE
- 30 Aug 2023 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED